The variant surface glycoprotein (VSG) of trypanosomes is attached to the cell surface by means of a phosphatidylinositol-containing glycolipid membrane anchor. The studies presented in this paper support the hypothesis that the transfer of VSG from trypanosomes to erythrocytes could lead to one of the pathological features associated with trypanosome infection-i.e., anemia. Migration of trypanosome VSG from live trypanosomes to target cells (sheep erythrocytes) could be shown by preincubating erythrocytes with trypanosomes and subsequently testing the washed erythrocytes for insertion of VSG by their susceptibility to lysis by complement in the presence of an anti-VSG antibody. Complementmediated lysis was found to depend on the strain-specific anti-VSG antibody used. Extent of erythrocyte lysis increased with time of cell exposure to trypanosomes and with trypanosome concentration. No erythrocyte lysis was observed when trypanosomes were preincubated with anti-VSG antibody before adding erythrocytes. Purified membrane-form VSG (which retains the glycolipid anchor), but not soluble VSG (which no longer has the terminal diacylglycerol moiety), could sensitize erythrocytes to anti-VSG antibody-mediated complement lysis. The intermembrane transfer of VSG from trypanosomes to cells of the infected host could provide a molecular mechanism for the pathogenesis of trypanosomiasis.
ABSTRACT
The variant surface glycoprotein (VSG) of trypanosomes is attached to the cell surface by means of a phosphatidylinositol-containing glycolipid membrane anchor. The studies presented in this paper support the hypothesis that the transfer of VSG from trypanosomes to erythrocytes could lead to one of the pathological features associated with trypanosome infection-i.e., anemia. Migration of trypanosome VSG from live trypanosomes to target cells (sheep erythrocytes) could be shown by preincubating erythrocytes with trypanosomes and subsequently testing the washed erythrocytes for insertion of VSG by their susceptibility to lysis by complement in the presence of an anti-VSG antibody. Complementmediated lysis was found to depend on the strain-specific anti-VSG antibody used. Extent of erythrocyte lysis increased with time of cell exposure to trypanosomes and with trypanosome concentration. No erythrocyte lysis was observed when trypanosomes were preincubated with anti-VSG antibody before adding erythrocytes. Purified membrane-form VSG (which retains the glycolipid anchor), but not soluble VSG (which no longer has the terminal diacylglycerol moiety), could sensitize erythrocytes to anti-VSG antibody-mediated complement lysis. The intermembrane transfer of VSG from trypanosomes to cells of the infected host could provide a molecular mechanism for the pathogenesis of trypanosomiasis.
African trypanosomes are primarily bloodstream parasites, but some of the organisms escape the vascular environment and proliferate in the interstitial tissue. Wherever these parasites localize, inflammatory reactions occur that lead to a multitude of pathological sequelae. While the most common feature of clinical and experimental African trypanosomiasis is anemia, other consequences of extravascular localization of the parasite include meningoencephalitis, splenomegaly, and cachexia.
The molecular events associated with the pathogenesis of African trypanosomiasis are poorly understood. Intracellular parasites are not usually found, nor is there evidence that the parasites produce a toxic factor. The hypothesis examined in this report is that the membrane form of the variant surface glycoprotein (mfVSG) of trypanosomes can, under the appropriate circumstances, transfer from the parasite plasma membrane to that of a target cell. Such intermembrane transfer of variant surface glycoprotein (VSG) can provide a model for the pathogenesis of trypanosomiasis.
Trypanosome VSG belongs to a group of proteins that are anchored in the plasma membrane by means of a phosphatidylinositol-containing glycolipid covalently attached by ethanolamine to the C-terminal end of the protein (1) . Similar glycolipid moieties have been described for erythrocyte acetylcholinesterase (2) and decay accelerating factor (DAF) (3, 4) . The intermembrane transfer of acetylcholinesterase from erythrocytes to liposomes (5) and the selective incorporation of DAF from a crude preparation into an acceptor cell (6) suggest that membrane proteins having such glycolipid anchors are able to partition between the different lipid environments of the donor membrane (e.g., the erythrocyte plasma membrane for acetylcholinesterase) and the target membrane (e.g., liposomes). The rate, direction, and extent of such intermembrane transfers depend on the relative lipid composition and fluidity of the donor and acceptor (or target) membranes (7) .
In this paper, we report that after in vitro incubation with trypanosomes, erythrocytes become sensitive to anti-VSG antibody-mediated complement lysis. The data provide clear evidence for the transfer of mfVSG from trypanosomes to a target membrane. This transfer of mfVSG may sensitize the cells to immune destruction and contribute to the anemia associated with African trypanosomiasis.
MATERIALS AND METHODS
Trypanosomes. The following strains of Trypanosoma brucei were used: strain 427, variant 117 (also known as MiTat 1.4) (8), strain TREU 667 (9) , and strain EATRO 110 (10) . Three days after intraperitoneal inoculation, trypanosomes were harvested from infected rat or mouse blood by differential centrifugation and DEAE-cellulose chromatography (11) . Trypanosomes, resuspended in minimum essential medium with Earle's salts (MEM) (GIBCO), were kept on ice and used immediately after purification.
Preincubation of Erythrocytes with Trypanosomes, Soluble VSG, and mfVSG. Fresh sheep blood was mixed with an equal volume of Alsever's bovine serum albumin and stored at 40C for at least 5 days, but <28 days, before use. Sheep blood >4 weeks old gave high antibody-independent lysis values and, hence, was not used in these studies. Before each experiment, sheep erythrocytes were washed three to five times with barbital buffer (3 mM barbital/1.8 mM sodium barbital/145 mM NaCl/0.15 mM CaCl2/0.5 mM MgC12, pH 7.4), until the supernatants were free of hemoglobin. Washed sheep erythrocytes were resuspended in barbital buffer at a concentration of 109 cells per ml. The soluble form of VSG (sVSG), which lacks the C-terminal glycolipid moiety, was isolated by the method ofCross (12) , and mfVSG was purified by the method of Hereld et al. (13) . Purity of sVSG and mfVSG was verified by SDS/urea acrylamide gel electrophoresis (14) .
For each experiment, an aliquot of washed sheep erythrocytes was centrifuged to pellet the cells. The cells were resuspended in MEM containing either trypanosomes, sVSG, or mfVSG. In most experiments the final concentrations were as follows: 5 x 10' sheep erythrocytes per ml and 108 trypanosomes per ml or 0.02 mg of sVSG or mfVSG per ml. After incubation at 37°C for up to 30 min, cold buffer was Abbreviations: VSG, variant surface glycoprotein; sVSG, soluble VSG; mfVSG, membrane-form VSG.
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added to cool and dilute the cell suspension. The tubes were centrifuged at 200 x g for 10 min to pellet most of the erythrocytes while leaving most of the trypanosomes in the supernatant. The erythrocytes were washed three times and then resuspended in barbital buffer to a concentration of 109 cells per ml.
Complement Lysis Assay. Guinea pig serum, obtained from Miles Scientific, was absorbed three times with washed sheep erythrocytes (0.3 ml packed cells per 10 ml of serum). Small aliquots were stored at -20'C and used as a source of complement. Anti-sVSG rabbit serum was prepared by immunizing New Zealand White rabbits with purified T. brucei variant 117 sVSG (15) . The agglutination titer of this antiserum with live trypanosomes was 1:400. Rabbit serum was inactivated by incubation at 560C for 30 min and stored in 1.0-ml aliquots at -70'C.
To duplicate tubes at 0C, the following were added in order: 0.2 ml of sheep erythrocytes (previously incubated with trypanosomes and washed, as described above), 0.2 ml of anti-sVSG antiserum (diluted 1:100 in barbital buffer), and 2.6 ml of guinea pig complement (diluted 1:200 in barbital buffer). The tubes were incubated at 370C for 90 min with occasional shaking and then centrifuged at 800 x g for 15 min. Optical density of the supernatant was determined at 540 nm to measure the amount of hemoglobin released. For each experiment, 100% lysis values were obtained by mixing 0.2 ml of washed sheep erythrocytes with 2.8 ml of 0.1% Na2CO3. Control tubes contained sheep erythrocytes that had been preincubated in MEM only, instead of with trypanosomes. Lysis in control tubes was usually very low (about 1-3%) but increased with the age of erythrocytes (up to 18%). The data are presented as % specific lysis, defined as [(% lysis with anti-sVSG antibody) -(% lysis without antibody)].
In initial experiments mouse, rat, and human erythrocytes were used as target cells with human, rat, or guinea pig serum as a source of complement (in heterologous combinations). In the best of these experiments, specific anti-VSG antibodymediated lysis was noted at levels only twice the lysis in the absence of antibody. In contrast, the classical assay combination for complement-mediated immune lysis consisting of sheep erythrocytes, rabbit antibody, and guinea pig complement (16) gave very little lysis (<2%) in the absence of anti-VSG antibody and up to 90% lysis in the presence of anti-VSG antibody. Therefore, all experiments reported here used this combination of sheep erythrocytes, rabbit antibody, and guinea pig complement; experiments with cow erythrocytes as target cells gave similar results but the percent specific lysis was about half that observed with sheep cells. These results are consistent with observations by others that erythrocytes from different species vary widely in their sensitivity to immune hemolysis, even when purified antibodies and complement components are used; human erythrocytes, in particular, appear to be relatively resistant to immune hemolysis, whereas sheep and bovine cells lyse more readily (17, 18) .
Neuraminidase Treatment. Sheep erythrocytes were washed twice with 20 mM Tris maleate buffer, pH 5.5/145 mM NaCl (TM buffer) and resuspended in TM buffer to 5 x 108 cells per ml. After addition of neuraminidase (Vibrio cholerae, Calbiochem) (0.1 unit per 4 x 109 cells), the erythrocytes were incubated at 37°C. After either 30 or 60 min, the incubation tubes were placed on ice, and an equal volume of cold TM buffer was added. Control cells were incubated without enzyme at 37°C for 60 min. The cells were pelleted by centrifugation (800 x g, 10 min) at 4°C, washed three times in barbital buffer, and resuspended to 109 cells per ml. A portion of the neuraminidase-treated cells was used for complement lysis assays as described above. The remainder of the treated erythrocytes was pelleted, resuspended in 40 vol of distilled water to lyse the erythrocytes, and centrifuged (25,000 x g, 20 min) to pellet the ghosts. The ghosts were resuspended in 0.4 M H2SO4 and digested at 80'C for 60 min to release sialic acid. The ghosts were pelleted by centrifugation, and the supernatant was saved for sialic acid determination by the thiobarbituric acid assay (19) . Fig. 1 outlines the experimental protocol used to demonstrate the intermembrane transfer of VSG from trypanosomes to a target, or acceptor, cell. In the experiments reported here, sheep erythrocytes were used as the target cell; similar results were obtained with erythrocytes from cattle, a natural host for African trypanosomes. The proposed model predicts that during the first incubation (step 1) VSG transfers from live trypanosomes to erythrocytes. The presence of transferred VSG on the surface of erythrocytes is then tested in the second incubation (step 2) by the ability of added anti-VSG antibody and complement to lyse the sensitized erythrocytes.
RESULTS
The results in Table 1 show that erythrocytes, after incubation with trypanosomes, become sensitive to lysis by complement in the presence of anti-VSG antibody, as depicted in Fig. 1 , and illustrate the immunological specificity of the phenomenon. When preimmune serum was used or when anti-VSG antibody was omitted, no lysis was observed. Moreover, negligible erythrocyte lysis was observed when two different strains of T. brucei, not recognized by the anti-117 VSG antibody, were used at 10-fold and 30-fold higher concentrations. Thus, lysis is specific with respect to the antigenic properties of the trypanosomes used.
To assess whether the transfer of VSG from trypanosomes to erythrocytes depends on the incubation medium, the growth medium of Baltz (20) was compared with MEM alone. Phase-contrast microscopy of the trypanosomes after incubation showed no difference in the percentage of dead cells (1-2%). However, lysis of target cells was found to be decreased by a factor of 3-5 when Baltz medium was used. In a similar experiment performed with sheep whole blood, lysis of erythrocytes also occurred at a reduced level (20% specific lysis after 30 min). These results suggest that either less VSG is released when trypanosomes are incubated in more physiological media or that the albumin in these media binds some of the released VSG.
The kinetics of transfer of VSG from trypanosomes to erythrocytes was studied by incubating trypanosomes with DONOR TARGET trypanosomes rmc-. Specific lysis of erythrocytes also depends on the trypanosome concentration during the first incubation, as shown in Fig. 3 . Similar results were obtained whether live or freezethawed trypanosomes were used, except that the extent of lysis was always higher when equivalent numbers of freezethawed trypanosomes were used (cf. Table 1 ). Preincubation of erythrocytes with dead strain 117 at 107 cells per ml led to significant lysis, whereas preincubation with dead strain 110 at 3 x 108 cells per ml did not (Table 1) . Thus, it is unlikely that the enhanced lysis observed with freeze-thawed trypanosomes was due to release of a toxic, nonspecific lytic molecule.
Trypanosomes disrupted by sonication or osmotic lysis are known to release 90% of their VSG, mostly as sVSG (12) . A slow release of sVSG from live trypanosomes has also been described (21, 22) . To find out whether this form of VSG, which lacks a hydrophobic anchor, can sensitize erythrocytes to antibody-mediated complement lysis, purified sVSG and mfVSG were incubated with erythrocytes. As shown in Table 2 , only mfVSG was effective, indicating that transfer of VSG from trypanosomes to erythrocytes requires the presence ofthe hydrophobic anchor. The results also indicate that the insertion of mfVSG into the acceptor (target) membrane occurs in an orientation that allows the protein to be recognized by specific antibody. Table 2 also shows that anti-VSG antibodies completely block the transfer when present in the first incubation step. This finding is consistent with the transfer of mfVSG from trypanosomes to erythrocytes by means of a transient partitioning of mfVSG into the aqueous phase because the presence of antibody would not only crosslink VSG molecules on the surface of trypanosomes but would also form complexes with any VSG molecules that might have desorbed from the trypanosome membrane. Thus, this mechanism of VSG transfer is similar to that described for intermembrane protein transfer in other systems (23, 24)-i.e., via protein monomers or dimers in the aqueous phase.
Because the presence of antibody during the incubation of erythrocytes with trypanosomes prevents the transfer of :> 60F Cell Biology: Rifkin and Landsberger 108 dead cells per ml + anti-117 VSG 2.3 sVSG and mfVSG were added at 0.02 mg per ml, which is equivalent to the total concentration of VSG on 1.3 x 107 cells per ml. Trypanosomes were killed by three sequential freeze-thaw cycles.
VSG, trypanosomes remaining in the second incubation step would probably not contribute to the observed erythrocyte lysis. This hypothesis was tested directly by adding trypanosomes at 106 per ml to the second incubation step. No difference in lysis was found with or without added trypanosomes. Because in most experiments at least 90o ofthe initial trypanosomes are washed out, we can conclude that the contribution of contaminating trypanosomes to the specific lysis is negligible.
To determine whether the charge on the erythrocyte plays a role in the ability of erythrocytes to act as acceptor cells for transfer of mfVSG from trypanosomes, erythrocytes were treated with neuraminidase and then tested for the presence of VSG on their surface by antibody-mediated complement lysis after incubation with trypanosomes. No difference was found between control cells and neuraminidase-treated cells (Table 3) .
DISCUSSION
The molecular events associated with the diverse pathological sequelae of trypanosomiasis remain poorly understood. The hypothesis examined in this paper was whether changes in antigenic properties or functions of cells of the infected host might be explained by the insertion of trypanosome mfVSG into the plasma membrane of the host cell by means of an intermembrane protein transfer mechanism.
Intermembrane protein transfer is a phenomenon that has been described previously for a variety of membrane proteins, not only those anchored via a phosphatidylinositolglycan moiety (acetylcholinesterase) (7) but also those with amphipathic membrane binding properties (apolipoproteins C) (22) and with hydrophobic peptide membrane-spanning regions (erythrocyte band 3, cytochrome b5) (25) (26) (27) . Kinetic studies ofthese systems are consistent with models of protein transfer through an aqueous phase and rule out models that require membrane fusion or collision to effect transfer. An aqueous transfer mechanism also readily explains the findings that protein is transferred in native orientation-i.e., the protein on the target, or acceptor, membrane exhibits the same susceptibility to enzyme digestion as on the donor membrane (25) . These published findings suggested by analogy that trypanosome VSG could transfer to a target cell and that insertion of VSG into the target cell could result in changes in the antigenic, metabolic, or functional properties of that cell.
In this paper we have demonstrated the intermembrane transfer of trypanosome VSG from living trypanosomes to a target cell (the erythrocyte). This intermembrane transfer confers to the target cell antigenic properties that allow it to be recognized by specific anti-VSG antibody and lysed by complement, indicating that VSG inserts into the target membrane in native orientation. The insertion into the target membrane requires the hydrophobic glycolipid anchor because erythrocytes become sensitive to anti-VSG-mediated complement lysis only after incubation with mfVSG but not with sVSG.
The role of charge interactions between the protein being transferred and charges on the acceptor plasma membrane contributed by phospholipid headgroups or amino acid or sugar side chains of membrane proteins has not been extensively studied in other systems. We have shown ( (28, 29) . Moreover, the degree of anemia in acute infections can be correlated with the number of circulating parasites (30) . Our hypothesis that intermembrane transfer of VSG from trypanosomes to erythrocytes occurs in vivo also explains the previously published findings that parasite antigens and immune complexes were found on erythrocytes during trypanosome infections (28, 31) . Thrombocytopenia, another common clinical complication of trypanosomiasis (32), can be explained by a similar mechanism of transfer of VSG to platelets, followed by anti-VSG antibody-mediated aggregation and destruction. Cachectin/ tumor necrosis factor production is stimulated by addition of freeze-thawed trypanosomes to macrophages (33) . Thus, cachexia may be the end result of mfVSG transfer to macrophages. Of interest is whether transfer of mfVSG to cells of the central nervous system can alter the function of these cells and be responsible for the neurological disorders associated with late stages of trypanosomiasis.
Intermembrane protein transfer may also contribute to the pathogenesis of other parasitic infections, such as malaria and schistosomiasis. In malaria, splenic clearance of nonparasitized erythrocytes is well documented (34) and appears to be, in part, responsible for the anemia associated with malaria infections (35) . The degree of anemia that develops, even in subclinical infections, is greater than that expected from peripheral blood parasitemia. Because merozoites are known to have a phospholipid-linked membrane protein on their surface (36) , this protein could also transfer to nonparasitized erythrocytes, with consequent binding of antibody and clearance of these cells by the reticuloendothelial system. In schistosomiasis, the schistosomule membrane acquires host molecules, such as glycolipids and major histocompatibility antigens (37) , and thereby contributes to antigen mimicry of the parasite. The mechanism of transfer of host molecules to the worm surface remains poorly understood. A mechanism involving intermembrane transfer, similar to that which we have described for trypanosome VSG, may also be operative in the acquisition of host antigens by schistosomes.
There remain many unanswered questions associated with the proposed model that transfer of VSG from trypanosomes to target cells of the infected host is responsible for the pathogenesis of trypanosomiasis. What are the properties of the target cell that regulate transfer? Clearly not all host cells acquire trypanosome antigens. Does insertion of mfVSG into a target cell also affect the cell's function or metabolism? If so, is the altered state permanent or transient? Is there cooperativity in the transfer of VSG to target cells-i.e., does the first transferred VSG molecule confer properties to the target cell that render it a more effective acceptor of other VSG molecules?
